Usability Evaluation of the Intelligent Fingerprinting Drug Screening System

This is a prospective performance evaluation of usability of the Intelligent Fingerprinting Drug Screening System, conducted in clinic. The total number of healthy adult subjects (male and female) required for enrollment in this study protocol is 45: 15 operators and 30 donors (ideally two donors assigned to one operator). The total duration of the study, from check-in through the end of the study will be 2-4 hours for each donor subject.

NCT Number	NCT07758777
Lead Sponsor	Intelligent Bio Solutions Inc.
Conditions	Healthy Adult Participants
Enrollment	45 participants
Start Date	2026-07-20
Primary Completion	2026-07-24 (estimated)
Study Completion	2026-07-24 (estimated)
Updated on ClinicalTrials.gov	2026-08-11